Infertility

Survey Reveals Women Trying to Get Pregnant Report Loneliness and Self-Blame

Retrieved on: 
Thursday, May 2, 2024
Research, Women, Parenting, Baby, Maternity, Men, Family, General Health, Consumer, Health, Science, Psychological Services, Education, Weill Cornell Medicine, NIAW, Pregnancy, Social media, Woman, Infertility, Insemination, Partnership, Fertility, Emotion, Friends, Reproductive medicine, Church & Dwight, Movement, Fertilisation, Birth control

A new survey commissioned by First Response™ in collaboration with RESOLVE: The National Infertility Association shows that women report feeling lonely, blame themselves and find misinformation as they are trying to get pregnant.

Key Points: 
  • A new survey commissioned by First Response™ in collaboration with RESOLVE: The National Infertility Association shows that women report feeling lonely, blame themselves and find misinformation as they are trying to get pregnant.
  • More than two-thirds of women trying to conceive (68%) are worried about their ability to become pregnant and one-third were concerned that not being able to get pregnant would be their fault (32%).
  • Almost 2 in 5 women who are trying (38%) wish they knew how much conflicting information there was before they began attempting to get pregnant.
  • 93% of women believe at least three misconceptions about trying to get pregnant when given a knowledge test about common facts regarding pregnancy.

Hera Biotech Announces Positive Interim Results From Endometriosis Diagnostic Study

Retrieved on: 
Tuesday, April 23, 2024
General Health, Professional Services, Consumer, Technology, Artificial Intelligence, Genetics, Health Technology, Data Analytics, Clinical Trials, Women, Biotechnology, Health, University, Executive, Woman, Hera, Infertility, Endometriosis, Uterus, Female, PCR, DRS, Disease, Therapy, Patient, CSO, Diagnosis, Biomarker, AUC

Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test.

Key Points: 
  • Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test.
  • “This result suggests that Hera’s molecular diagnostic test has the potential to replace surgical diagnosis and greatly improve the woefully inadequate state of endometriosis diagnosis and treatment that exists today,” said Hera Biotech CEO Somer Baburek.
  • Hera is focused on a tissue based approach for diagnosing endometriosis, utilizing a pipelle to non-surgically obtain endometrial cells for analysis.
  • Based on these promising results, Hera intends to bring a rapid bulk PCR endometriosis diagnostic test to market in 2025.

National Infertility Awareness Week: ARC Fertility Supports Family Building Act, Advocates Alongside RESOLVE and American Society for Reproductive Medicine

Retrieved on: 
Monday, April 22, 2024
LGBTQ+, Professional Services, Family, Consumer, Hospitals, Advocacy Group Opinion, Health Insurance, Parenting, Baby, Maternity, Insurance, Congressional News, Views, Health, Public Policy, Government, Congress, Fertility, NIAW, ARC, Infertility, MD, Member of Congress, Partnership, Senate, FACS, IVF, FRCSC, Observation, Reproductive medicine, Patient, Legislation, Society, Access, ASRM, FACOG, Organization

ARC® Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly recognizes National Infertility Awareness Week ® (NIAW), an event founded by RESOLVE in 1989.

Key Points: 
  • ARC® Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly recognizes National Infertility Awareness Week ® (NIAW), an event founded by RESOLVE in 1989.
  • “During this significant observation, ARC Fertility also reaffirms its commitment to supporting legislative measures that enhance access to family-building services,” says David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility.
  • “We proudly announce our support for the Access to Family Building Act sponsored by U.S.
  • ARC Fertility has a longstanding history of collaboration with RESOLVE and other advocacy organizations in the field of reproductive health.

Reproductive Medicine Associates Network Top Ranked in Newsweek’s ‘America’s Best Fertility Clinics’

Retrieved on: 
Monday, April 22, 2024
Women, Baby, Maternity, Genetics, LGBTQ+, Men, Family, Other Health, Health, Consumer, Infertility, Fertility, Research, Genetic testing, IVF, Newsweek, Embryo, ART, RMA, Reproductive medicine, Professional, Basking Ridge, New Jersey, Patient, IUI, Ovulation, Reproductive endocrinology and infertility, Birth control

Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, today announced that four clinics in its network were ranked in Newsweek’s 2024 list of America’s Best Fertility Clinics .

Key Points: 
  • Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, today announced that four clinics in its network were ranked in Newsweek’s 2024 list of America’s Best Fertility Clinics .
  • RMA Basking Ridge , was ranked the 11th best fertility clinic in the country.
  • RMA King of Prussia , Conceptions Reproductive Associates of Colorado , and RMA Seattle also ranked among the top 125 U.S. fertility clinics.
  • “We are honored that several of our facilities, including our Basking Ridge headquarters, ranked among the top fertility clinics in the country,” said Lynn Mason, CEO.

ARC Fertility challenges community to #LeaveYourMark for National Infertility Awareness Week

Retrieved on: 
Monday, April 22, 2024
Women, Men, General Health, Health, Family, Baby, Maternity, Health Insurance, Consumer, Fertility, NIAW, Social media, ARC, Infertility, Parent, Life, Reproductive medicine, Patient, Work, Society, ASRM, Birth control

ARC® Fertility , a national provider of innovative family-forming benefits, is calling upon its community of patients and the wider infertility community to #LeaveYourMark during National Infertility Awareness Week (NIAW), April 21-27.

Key Points: 
  • ARC® Fertility , a national provider of innovative family-forming benefits, is calling upon its community of patients and the wider infertility community to #LeaveYourMark during National Infertility Awareness Week (NIAW), April 21-27.
  • Organized annually by RESOLVE: The National Infertility Association, NIAW is the largest public awareness campaign that addresses this public health issue which affects 1 in 6 people worldwide.
  • ARC is calling upon the tens of thousands of patients whom it has helped start families to share their stories and support RESOLVE during NIAW.
  • “It is now more urgent than ever for the community of infertility doctors and patients to seize this moment to educate lawmakers and the broader public,” said Dr. David Adamson, founder and CEO of ARC Fertility.

Reproductive Medicine Associates Celebrates National Infertility Awareness Week with Free Educational Events

Retrieved on: 
Wednesday, April 17, 2024
Men, Research, Other Health, General Health, LGBTQ+, Family, Consumer, Genetics, Parenting, Science, Baby, Maternity, Women, Health, Well, Fertility, NIAW, Learning, Social media, Infertility, Fertility clinic, IVF, RMA, Reproductive medicine, Patient, Ageing, Reproductive endocrinology and infertility, Knowledge, Birth control

Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, announced a series of free educational and promotional initiatives to coincide with National Infertility Awareness Week (NIAW), April 22-26, 2024.

Key Points: 
  • Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, announced a series of free educational and promotional initiatives to coincide with National Infertility Awareness Week (NIAW), April 22-26, 2024.
  • This educational series is designed to provide up-to-date information about a variety of topics related to fertility, including egg freezing, IVF, and more.
  • What You Can Do To Optimize Your Fertility: Lessons from Studies on Healthy Aging (YouTube) (10 AM EST)
    How Long Until I’m Pregnant After Visiting a Fertility Clinic?
  • Other educational resources, RMA in-office giveaways, and internal promotions will be announced across RMA’s social media.

Posterity Health Launches Hormone Management Program: Helping Every Male Feel Their Best

Retrieved on: 
Tuesday, April 16, 2024
Women, Parenting, Baby, Maternity, LGBTQ+, Men, Family, General Health, Pharmaceutical, Consumer, Health, Infertility, Testosterone, Male, Fertility, Fellow, Erectile dysfunction, Patient, Fatigue, Urology, Birth control

Posterity Health, the Center of Excellence for Male Care, proudly announces the launch of its innovative Hormone Management Program.

Key Points: 
  • Posterity Health, the Center of Excellence for Male Care, proudly announces the launch of its innovative Hormone Management Program.
  • The new service is focused on helping every male feel their best by addressing the common issue of low testosterone.
  • The service expansion reinforces our commitment to making male health care more accessible," said Pam Pure, Founder and CEO at Posterity Health.
  • With a team of top Reproductive Urologists and innovative care approaches, Posterity Health is committed to revolutionizing male care with personalized solutions for men’s health and fertility.

Global Fertility Services Market Insights and Forecasts, 2020-2023, 2024 and 2025-2030 with Analyst Recommendations and Profiles of Key Players - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 11, 2024
Parenting, Health, Consumer, Other Health, Medication, Diagnosis, Pregnancy, Policy, Infertility, SWOT analysis, Fertility, Uterus, IVF, Tubing (recreation), Disease, ART, STI, Poverty, Reproductive technology, Movement, Research, Failure, Unsafe abortion, Da Vinci Surgical System, Endocrine system, Channel, LMIC, Genetic testing, Birth control

The "Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.
  • The report presents the analysis of Fertility Services Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report also studies the Fertility Services Market By Channel (Fertility Clinics, Hospitals, Research Institutes, and Others) and By Services (IVF, Genetic Testing, and Reproductive Tissue Storage and Donor Services).
  • Also, the attractiveness of the market has been presented by region, By Gender, By Treatment Type, By Channel, & By Services.

Nonprofits from Inception Fertility and Caden Lane Team Up to Expand Financial Accessibility to Fertility Care

Retrieved on: 
Friday, April 26, 2024
Education, Hope, PGT, Infertility, Partnership, Research, Parent, IVF, ART, Family, Patient, Child, Diagnosis, Prelude, Inception, Birth control

HOUSTON, April 26, 2024 /PRNewswire/ -- The Wyatt Foundation and The Conceive Fertility Foundation announce today a joint partnership that will award $15,000 grants to five individuals/couples who need in vitro fertility (IVF) to build their families. Launching during National Infertility Awareness Week (April 21-27, 2024), this partnership aims to raise awareness, offset treatment costs, and support research for more affordable fertility care options.

Key Points: 
  • Launching during National Infertility Awareness Week (April 21-27, 2024), this partnership aims to raise awareness, offset treatment costs, and support research for more affordable fertility care options.
  • The organization was started by TJ Farnsworth, the founder and CEO of Inception Fertility™, and his wife Margaret Farnsworth, who successfully conceived their first child, Wyatt, through IVF.
  • The Conceive Fertility Foundation is the nonprofit arm of Caden Lane , a direct-to-consumer lifestyle brand of baby products focused around the birth of a child.
  • Katy Mimari, CEO of Caden Lane, launched The Conceive Fertility Foundation after her own experience with infertility and understanding the financial barriers that prevent some aspiring parents from building their families.

BioInnovation Institute & Science announce the launch of the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine

Retrieved on: 
Thursday, April 25, 2024
Science Translational Medicine, Woman, Infertility, Health, Male, Innovation, Entrepreneurship, Research, Female, Birth, Ferring Pharmaceuticals, Women's Health Initiative, Women's health, Journal, BII, Pharmaceutical industry

COPENHAGEN, Denmark, April 25, 2024 /PRNewswire/ -- BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine.

Key Points: 
  • COPENHAGEN, Denmark, April 25, 2024 /PRNewswire/ -- BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine.
  • The introduction of the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine recognizes researchers who have developed innovative advances with translational potential to impact women's health and gender medicine globally.
  • The winner will have their essay published in the Journal, Science Translational Medicine, and will receive a cash reward of $25,000 to further progress their research.
  • Its Women's Health Initiative aims to support women's health start-ups and projects across a broad range of indication areas.